Czarnecka, Anna M <br/><br/>
Future perspectives for mTOR inhibitors in renal cell cancer treatment.  [electronic resource] 

 -  Future oncology (London, England)  2015 
 - 801-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1744-8301 
<br/><br/><label>Standard No.: </label>10.2217/fon.14.303  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Autophagy--drug effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Clinical Trials as Topic<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Neoplastic Stem Cells--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Treatment Outcome